Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 68071-4861 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PDP - 68071 4861 3

PDP - 68071 4861 3

This is a description of a medication called Atorvastatin Calcium 10mg manufactured by NuCare Pharmaceuticals, Inc. It is a film-coated white tablet that comes in a bottle of 30 tablets. Each tablet contains 10mg of Atorvastatin Calcium. The bottle contains a Lot#: 000000 and an expiration date of 00-00. The medication is for prescription-only use, and a warning to keep it out of reach of children is included. The bottle should be stored at a controlled temperature between 68-77°F. The label contains various identifying codes, including an NDC (68071-4861-3) and a GTIN (00368071486131). The label also includes instructions to call a doctor for medical advice about side effects and to report side effects to the FDA.*

Chemical Structure - atorvastatin calcium tablets 1

Chemical Structure - atorvastatin calcium tablets 1

Figure 1 - atorvastatin calcium tablets 2

Figure 1 - atorvastatin calcium tablets 2

This is a graph showing the cumulative incidence in percentage of an event over a period of 35 years. The event is not specified in the given text. The graph also displays a Hazard Ratio (HR) of 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005.*

Figure 2 - atorvastatin calcium tablets 3

Figure 2 - atorvastatin calcium tablets 3

The text represents statistical data related to a medical study. It shows the cumulative hazard percentage, the hazard ratio, and the time to first primary endpoint through four years of follow-up. The study suggests a significant correlation between the analyzed factors, however, no further context is given.*

Figure 3 - atorvastatin calcium tablets 4

Figure 3 - atorvastatin calcium tablets 4

This is a presentation of the percentage of subjects who experienced an event over time and how it was affected by taking Atorvastatin at different doses. The table displays that there is no data available for the 10mg dose and that the 80mg dose resulted in a hazard ratio of 0.78 with a P-value of 0.0002. The graph shows the time it took for the first major cardiovascular endpoint to occur in years.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.